What is the difference between alert and action limits in environmental monitoring?

1The two definitions.

EU GMP Annex 1, Manufacture of Sterile Medicinal Products, revised in August 2022 and in operation since 25 August 2023, defines both terms.¹

• An alert level is “an established relevant measure (e.g. microbial, or airborne particle levels) giving early warning of potential drift from normal operating conditions and validated state, which does not necessarily give grounds for corrective action but triggers appropriate scrutiny and follow-up to address the potential problem”. It is set from routine and qualification trend data, periodically reviewed, and can be based on adverse trends, individual excursions above a set limit and repeat events.
• An action limit is “an established relevant measure (e.g. microbial, or airborne particle limits) that, when exceeded, should trigger appropriate investigation and corrective action based on the investigation”.

FDA’s guidance Sterile Drug Products Produced by Aseptic Processing (September 2004) uses alert level and action level with nearly the same wording, and adds that “alert levels are always lower than action levels”.² MHRA’s out-of-specification guidance uses warning level and alert level for the same thing.³

In the US the legal basis is 21 CFR 211.42(c)(10)(iv), which requires aseptic processing to include, as appropriate, “a system for monitoring environmental conditions”.⁴ The levels themselves come from guidance and from the manufacturer’s own procedures.

2How they compare.

The rows on setting and response are from Annex 1 sections 9.9 to 9.13.¹

3The maximum action limits in Annex 1.

Table 6 of Annex 1 sets maximum action limits for viable particles.¹

For grade A, “any growth should result in an investigation”. Table 5 sets maximum total particle limits: for grade A, 3 520 particles of 0.5 µm or larger and 29 of 5 µm or larger per cubic metre, at rest and in operation. For grade D in operation the manufacturer sets the limit from a risk assessment and routine data.¹ Annex 1 does not set numeric alert levels; it says alert levels for grade A (total particles only) and grades B, C and D should be set so that adverse trends are detected and addressed.¹

FDA’s 2004 guidance gives recommended microbiological action levels by ISO class, such as 1 CFU/m³ of air for ISO 5, and says samples from ISO 5 environments “should normally yield no microbiological contaminants”. It notes that firms may set different levels for the nature of the operation or the method.²

4How to set alert levels.

Annex 1 says alert levels for viable and total particles should be established from cleanroom qualification results and reviewed periodically against ongoing trend data. Action limits can be stricter than Tables 5 and 6 “based on data trending, the nature of the process or as determined within the CCS”, the contamination control strategy.¹ For grades C and D, the levels depend on the nature of the operations.¹

FDA recommends basing monitoring levels on the sampled location’s relationship to the operation, and drawing on historical monitoring data, media fills, cleanroom qualification and sanitisation studies. Data from similar operations can help set alert and action levels for a new operation.²

The same pattern applies to pharmaceutical water. Annex 1 says water system alert levels should be based on initial qualification data and reassessed with later monitoring and investigation data.¹

5What an excursion triggers.

If an action limit is exceeded, Annex 1 says procedures should prescribe “a root cause investigation, an assessment of the potential impact to product (including batches produced between the monitoring and reporting) and requirements for corrective and preventive actions”. If an alert level is exceeded, they should prescribe “assessment and follow-up”, considering an investigation or corrective action to prevent further deterioration.¹ In grade A, the continuous particle monitoring system should raise an alarm when alert levels are exceeded, and grade B should have alarms too.¹ Organisms found in grades A and B should be identified to species level and their impact on each implicated batch evaluated.¹

FDA’s guidance says “a result at the alert level urges attention to the approaching action conditions” and “a result at the action level should prompt a more thorough investigation”. In the absence of an adverse trend, a single result above an action level should trigger an evaluation of whether remedial measures are needed. Each result should be compared with the levels individually, because “averaging of results can mask unacceptable localized conditions”.²

6Trends matter as much as single results.

Annex 1 asks monitoring procedures to define the approach to trending, including at least:¹

1. increasing numbers of excursions from action limits or alert levels;
2. consecutive excursions from alert levels;
3. regular but isolated action limit excursions that may share a cause, such as excursions that always follow planned maintenance; and
4. changes in microbial flora type, numbers and predominant organisms, with attention to spore-formers and moulds.

FDA notes that monitoring methods do not always recover the organisms present, so consecutive growth is only one kind of adverse trend, and an increased incidence over a period is “an equal or more significant trend”.² MHRA says that if two or more consecutive samples exceed the alert level, or counts rise or the same organisms recur over a short period, consideration should be given to treating the results as action level excursions.³

7How it runs in Seal.

In Seal’s environmental monitoring, each sample keeps its location, collection window, media and incubation, and review rules are versioned. A rising series raises review work with its rule and source results attached, and the collection time, not the read date, identifies the batches and interventions that overlapped it. Changes to the sampling plan become new approved versions, and earlier and missed collections keep the plan they were taken under.

Neil can compare environmental monitoring results against sampling exposure, locations and operational context, and drafts a trend assessment with its sampling population; microbiology and QA assess each result against its alert and action limits. For water systems and clean utilities, qualification records the basis for alert and action levels, and that envelope becomes the reference for routine monitoring.